MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
subsidiary common shares,...
$193,605K
Proceeds from exercise of
the companys and...
$118,814K
(322.60%↑ Y/Y)
Contribution from minority
interest holder to...
$39,250K
Proceeds from maturities
of marketable...
$2,745,000K
Proceeds from issuance of
the companys common...
$381K
Proceeds from sales of
marketable securities
$200,766K
Purchase of property and
equipment
-$4,935K
(-370.11%↓ Y/Y)
Net cash provided by
(used in) financing...
$328,194K
(220.24%↑ Y/Y)
Net cash used in
investing activities
$109,470K
(-75.89%↓ Y/Y)
Effect of exchange rate
changes on cash, cash...
$430K
(140.30%↑ Y/Y)
Canceled cashflow
$23,856K
Canceled cashflow
$2,841,231K
Net change in cash,
cash equivalents and...
$241,610K
(988.44%↑ Y/Y)
Canceled cashflow
$196,484K
Taxes paid related to
net settlement of...
$23,856K
(176.53%↑ Y/Y)
Share-based compensation
$104,997K
(25.47%↑ Y/Y)
Other
-$29,324K
(-39.47%↓ Y/Y)
Change in fair value of
debt and liability...
-$24,416K
(-667.08%↓ Y/Y)
Impairment loss on
operating lease...
$15,594K
Accrued expenses
$8,580K
(382.89%↑ Y/Y)
Non-cash lease expense
$2,527K
(47.69%↑ Y/Y)
Depreciation and
amortization
$691K
(-76.34%↓ Y/Y)
something is missing
-$1,825,000K
Purchases of marketable
securities
$1,013,713K
(53.93%↑ Y/Y)
Other
$2,518K
Net cash used in
operating activities
-$196,484K
(5.20%↑ Y/Y)
Canceled cashflow
$186,129K
Net loss
-$313,701K
(-365.68%↓ Y/Y)
Change in fair value of
investments
$21,592K
(201.30%↑ Y/Y)
something is missing
-$21,025K
Other
$9,718K
(181.70%↑ Y/Y)
Accretion of discount and
amortization of premium on...
$8,723K
(-70.20%↓ Y/Y)
Accounts payable
-$3,988K
(-7485.19%↓ Y/Y)
Other current assets
$2,733K
(-93.45%↓ Y/Y)
Operating lease
liabilities
-$786K
(60.99%↑ Y/Y)
Realized gain from sales
of marketable...
$347K
Back
Back
Cash Flow
source: myfinsight.com
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)